We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy (T2DM)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01805830
First Posted: March 6, 2013
Last Update Posted: October 6, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Handok Pharmaceuticals Co., Ltd.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)